Summary.
The dopaminergic system is critically involved in reward mechanisms mediating the reinforcing effects of alcohol. The intention of this study was to investigate the genotypic frequencies of the −141C Ins/Del polymorphism of the DAD2 receptor gene as well as the Bal I polymorphism of the DAD3 receptor and their potential association with treatment outcome in alcoholism. Therefore, individuals suffering from primary alcohol dependence were clinically and genetically characterized and followed prospectively over a period of one year after inpatient treatment.
No association was found between DAD2 or DAD3 receptor gene variants and treatment outcome as reflected by abstinence/relapse after one year. Taking into account potential stratification effects, such as family history, gender, age of onset, or severity of the disease an association with DAD2 or DAD3 gene variants could neither be found. In conclusion, we found no evidence that the DAD2 or DAD3 gene variants investigated have a major influence on treatment outcome in primary alcohol dependence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received June 2002; accepted February 3, 2003 Published online April 22, 2003
RID="*"
ID="*" This paper is dedicated to Prof. Peter Riederer who celebrated his 60th birthday in March 2002
Authors' address: PD Dr. G. A. Wiesbeck, Addiction Research Group, Psychiatric Clinic, University of Würzburg, Füchsleinstrasse 15, D-97080 Würzburg, Germany, e-mail: wiesbeck_g@klinik.uni-wuerzburg.de
Rights and permissions
About this article
Cite this article
Wiesbeck, G., Weijers, HG., Wodarz, N. et al. Dopamine D2 (DAD2) and dopamine D3 (DAD3) receptor gene polymorphisms and treatment outcome in alcohol dependence. J Neural Transm 110, 813–820 (2003). https://doi.org/10.1007/s00702-003-0821-0
Issue Date:
DOI: https://doi.org/10.1007/s00702-003-0821-0